Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050596
Status:
COMPLETED
Last Update Posted:
2011-06-27
First Post:
2002-12-16
Brief Title:
Comparison Study of MDX-010 CTLA-4 Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
MDX010-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb